Commodifying Health: The Intersection of Biopower, Neoliberal Ideologies, and Naloxone Marketing in the United States

This paper presents a case study of the American naloxone market, employing the theoretical framework of biopower to scrutinize how neoliberal ideologies influence the corporate strategies of naloxone manufacturers. The research critically analyzes marketing materials and studies funded by pharmaceutical companies, aiming to expose the complex interplay between market forces and public health initiatives. The completed study confirms initial findings, revealing a significant interconnection between biopower, as conceptualized by Michel Foucault, and neoliberalism. This connection is evident in the marketing and distribution strategies of naloxone, which emphasize efficiency and profit maximization, potentially at the expense of patient care and accessibility. These strategies not only reflect the commodification of health but also exploit it, underscoring the ethical dilemmas inherent in pharmaceutical practices. The implications of this research are profound, extending beyond academic discourse to influence public health policies and practices. By elucidating the role of biopower in shaping corporate strategies, this case study contributes to a deeper understanding of the opioid crisis and the distribution of life-saving medications like naloxone. It advocates for a healthcare paradigm that prioritizes public health and ethical standards above market imperatives, calling for policy reforms to ensure equitable access to essential medications amidst the opioid epidemic.